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Introduction
Vascular homeostasis, and therefore cardiovascular dis-
ease risk, is partly governed by the vascular endothelium.1,2 
The gold-standard noninvasive approach for assessing 
endothelial function is the ultrasound-based flow-medi-
ated dilation (FMD) test.3,4 The FMD test measures an 
artery’s vasodilatory response to increased shear stress, 
where increased shear stress is induced by reactive hyper-
emia following 5 min of downstream ischemia.3,4 While 
the FMD test is highly valid, it is technically challenging, 
operator-dependent, and requires high levels of operator 
training.3,4 A simpler, user-objective test would be of high 
value to both epidemiological and physiological investiga-
tions. One potential test is the novel flow-mediated slow-
ing (FMS) technique.
FMS may be defined as the minimum pulse wave velocity 
(PWVmin) during reactive hyperemia, with a lower minimum 
thought to represent greater endothelial function.5–9 PWV, 
which is the speed at which the forward pressure wave trav-
els from a proximal to distal arterial segment, is considered 
the ‘gold-standard’ measure of arterial stiffness.10,11 However, 
the assessment of PWV during reactive hyperemia can also 
be used to reflect endothelial function.12–16 According to the 
Moens–Korteweg equation, PWV is directly proportional to 
the arterial wall width and Young’s modulus, and inversely 
proportional to blood viscosity and vessel diameter.17 Vessel 
diameter increases during FMD, due to endothelium-depend-
ent vasodilation.3,18 The endothelium-dependent increase in 
diameter would be expected to result in a reciprocal decline 
in PWV. However, while FMD and PWV are the most widely 
reported noninvasive assessments of endothelial function 
and arterial stiffness, respectively, FMS has garnered little 
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attention.5–9 Moreover, none of the known studies have 
investigated whether FMS is able to track acute changes in 
endothelial function.
Endothelial function naturally fluctuates throughout the 
day and is enhanced or impaired by external and internal fac-
tors which alter the local hemodynamic environment.2,19–23 
For example, while unidirectional shear stress enhances 
endothelial function,19 oscillatory shear stress can impair 
endothelial function.19–22 A model that we20 and others21,22 
have used to increase retrograde, and subsequently oscilla-
tory shear stress, and acutely impair endothelial function, is 
the inflation of a tourniquet to a low-moderate pressure (50–
75 mmHg) distal to the arterial segment of interest for 20-30 
min. The down-stream resistance, as the result of tourniquet 
inflation, increases retrograde and oscillatory shear stress. In 
turn, the oscillatory shear stress leads to diminished FMD 
(endothelial function).21,22 This model can be used to confirm 
whether PWV and FMS are able to similarly track acute 
impairments in endothelial function. Therefore, the objective 
of the current study was to determine the effects of acute 
local endothelial dysfunction, induced by increasing retro-
grade shear stress for 30 min in the upper arm, on arm PWV 
and PWVmin. It was hypothesized that acute local endothelial 
dysfunction would increase PWV and PWVmin.
Methods
This study is reported in accordance with CONSORT 
(Consolidated Standards of Reporting Trials) guidelines.24 
Ethical approval was obtained from the University of North 
Carolina at Chapel Hill Institutional Review Board, and all 
participants provided written informed consent prior to par-
ticipating in the study.
Participants
Twenty-three young (18–35 years), healthy individuals 
were recruited from the host institution, a large state uni-
versity. A healthy population sample was recruited to miti-
gate the risk of age or disease-related influences on the 
primary outcomes. Participants were excluded if they were 
pregnant, reported any known cardio-metabolic disorders, 
were taking medications known to affect cardiovascular 
function, or reported cigarette smoking.
Experimental design
This was a quasi-experimental, pretest–post-test design in 
which FMD and PWVmin were assessed pre- and post-acute 
local endothelial dysfunction. Following a familiarization 
visit, all measurements were collected on a single occasion 
in an environmentally controlled laboratory (average: 22°C, 
50% humidity, 748 mmHg). Participants arrived between 
0600 and 1000, having fasted for 12 h, consuming only 
water, and having refrained from supplement intake that 
morning. Additionally, participants were asked to avoid 
strenuous physical activity and alcohol for 24 h prior to 
experimentation. Following anthropometric assessments, 
participants were asked to rest quietly and supine for 20 min 
with both arms resting at right angles to the body and at 
heart level.25 During the 20-min rest period a blood pressure 
cuff attached to the SphygmoCor XCEL (AtCor Medical, 
Sydney, Australia) device was fitted to the right upper arm 
to permit collection of control hemodynamic assessments. 
Primary outcome apparatus, including ultrasound (LOGIQ 
P6; GE Healthcare, Wauwatosa, WI, USA) for FMD and 
Vicorder (Arterial Stiffness Model; SMT Medical, 
Wuerzburg, Germany) for PWV/PWVmin, were positioned 
on the left arm (Figure 1). The quality of ultrasound and 
Vicorder pressure waveform signals were adjudicated, and 
adjustments were made if the signals were not optimal.
Following a 20-min rest, the baseline brachial diameter 
(Dbase) and PWV were recorded. Subsequently, the maxi-
mum diameter (Dmax) and PWVmin response to reactive 
hyperemia were simultaneously recorded, where reactive 
hyperemia was induced by inflating a pneumatic tourni-
quet (SC10; Hokanson, Bellevue, WA, USA) around the 
mid-forearm to 250 mmHg for 5 min. Following a 3-min 
recovery, endothelial dysfunction was induced by inflating 
the mid-forearm tourniquet to a pressure of 75 mmHg 
(Figure 1). This moderate pressure does not prevent arte-
rial inflow, but does induce arterial wave reflections with 
resultant retrograde blood flow.20,21,26,27 Following 30 min 
of increased retrograde shear stress, the tourniquet was 
slowly (over 30 s) deflated, and then all assessments were 
immediately repeated as described above.
Experimental measures
Ultrasound: Flow-mediated dilation and shear rate. A 11-2 
MHz linear array probe (LOGIQ P6; GE Healthcare) was 
used to record brachial artery brightness-mode images and 
pulsed Doppler waveforms for the measurement of FMD 
and shear rate, respectively.3 Using a custom-built probe-
holding device, the ultrasound probe was fixed on the bra-
chial artery 5–10 cm proximal to the antecubital fossa. The 
insonation angle was kept constant between 45° and 60° and 
the sample volume included most of the vessel. For the 
entire FMD procedure, video recordings were captured at 
30 Hz using an external video capture system (AV.io HD 
Frame Grabber; Epiphan Video, Palo Alto, CA, USA). Dur-
ing the period of increased retrograde shear stress, one 30-s 
recording was captured to confirm increased retrograde 
shear rate. The captured videos were analyzed offline using 
specialized image analysis software (FMD Studio; Quipu 
srl, Pisa, Italy). The second-by-second diameter, antegrade 
velocity and retrograde velocity data were smoothed (3-s 
bins) and processed using custom-written Visual Basic 
code.20,28 FMD (%) was calculated as (Dmax – Dbase)/Dbase * 
100%, where Dbase is the mean diameter averaged over 2 
min preceding the cuff inflation period, and Dmax is the peak 
diameter response to reactive hyperemia (Figure 2). To esti-
mate the FMD stimulus, shear rate area-under-the-curve 
(AUC) up to 40 s (Shear AUC) after cuff release was calcu-
lated.28 Shear rate (s−1) was calculated as 4 * mean velocity/
diameter, and oscillatory index as retrograde shear rate/
(antegrade shear rate + retrograde shear) * 100.29
Pulse wave velocity and flow-mediated slowing. Simultaneous to 
FMD, the Vicorder device was used to measure PWV and 
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PWVmin. PWV (m/s) was calculated by dividing arterial path 
length by the pulse transit time between a proximal (upper 
arm) and distal (wrist) arterial segment. Specifically, path 
length was directly measured, using a custom device to 
bypass body contours, between the mid-point of the two 
cuffs. To measure pulse transit time, the cuffs were simulta-
neously inflated to a low (~50 mmHg) pressure, and a propri-
etary algorithm was used to automatically calculate the time 
between the foot of the proximal pressure waveform to the 
foot of the distal pressure waveform. As part of the FMS test, 
PWV was recorded continuously for 2 min prior to inflation 
of the forearm tourniquet used to induce reactive hyperemia 
(Figure 2). This 2-min recording was averaged to derive 
PWV. Subsequently, PWVmin was captured by continuously 
recording PWV during reactive hyperemia, and averaging 
PWV over 3.5-s cycles. PWVmin was also expressed as the 
change relative to baseline (PWVmin%), and the integrated 30 
(PWV30), 60 (PWV60), 90 (PWV90), and 120-s (PWV120) 
response relative to baseline.
Peripheral and central hemodynamics. The SphygmoCor 
XCEL (AtCor Medical) was used to measure peripheral 
and central BP as well as arterial wave reflection. An 
appropriately sized cuff was placed around the upper por-
tion of the right arm. Each measurement cycle lasts ~60 s. 
This includes inflating the cuff to measure brachial systolic 
(SBP) and diastolic (DBP) blood pressure, and then re-
inflating 5 s later to 10 mmHg below DBP to acquire a 
volumetric displacement signal for 10 s.30 The brachial 
waveforms are calibrated using the cuff-measured SBP and 
DBP, and mean arterial pressure (MAP) is derived by inte-
grating the AUC. A corresponding aortic pressure wave-
form is generated using a validated proprietary transfer 
function and calibrated using DBP and MAP.30 The aortic 
waveform is used to derive central SBP (cSBP), aortic 
backward pressure (Pb), and aortic forward pressure (Pf). 
The Pf and Pb wave pressures were determined by assum-
ing a triangular flow wave.31 This method creates a triangu-
lar-shaped flow wave by matching the start, peak, and end 
of the flow wave to the timings of the foot, inflection point, 
and incisura of the aortic pressure wave, respectively.
Sample size
Sample size calculations were made using GPower 3.1. A 
prior study reported that the endothelial dysfunction 
Figure 1. Experimental set-up.
To measure PWV at baseline, and then the minimum PWV during reactive hyperemia (FMS), arterial pressure waveforms were simultaneously cap-
tured at proximal (A) and distal (B) sites using an oscillometric device. Duplex Doppler ultrasound was used to measure brachial artery FMD, and to 
capture pulsed Doppler waveforms (C) at baseline (0 mmHg) and during the ED protocol (75 mmHg).
Ante, antegrade; ED, endothelial dysfunction; FMD, flow-mediated dilation; FMS, flow-mediated slowing; Osc, oscillatory; PWV, pulse wave velocity; 
Retro, retrograde.
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protocol used in the current study decreased FMD% from 
7.2% (SD: 3.0) to 4.2% (SD: 3.4), with an effect size (ES) 
of 1.0.21 Using a more conservative effect size of 0.5, a 
Type I error of 5% and Type II error of 20%, 21 subjects 
were required. This number was inflated to 23 to account 
for the potential for missing data.
Statistical analysis
Statistical analyses were performed using Jamovi (2019, 
Version 1.0.1) and the rmcorr (repeated measures correla-
tion) package for R (R Foundation for Statistical Computing, 
Vienna, Austria).32 Only participants who had complete 
data for the primary outcomes were included in the analy-
ses. The significance level was set a priori for all statistical 
procedures at α = 0.05. Raw data are presented as mean 
(SD) and mixed model data are presented as mean (95% 
CI). The corresponding author (LS) had full access to the 
data in the study and was responsible for the integrity of the 
data set and the data analysis.
The effect of endothelial dysfunction on PWV, PWVmin, 
and FMD were tested using paired Student’s t-tests. 
Additionally, linear mixed models (random intercept, fixed 
slope) were used to adjust FMD for within-subject changes 
in shear AUC, and to adjust PWV and PWVmin for within-
subject changes in MAP. Linear mixed models were also 
used to assess the effect of condition (baseline, during cuff 
inflation (endothelial dysfunction protocol), post-cuff infla-
tion) on hemodynamic data. When the condition effect was 
significant, during cuff inflation and post-cuff inflation 
were compared to baseline, with Bonferroni adjustments. 
Intra-individual (within-subject) associations between 
FMD with PWV and PWVmin were analyzed using rmcorr. 
The rmcorr statistical technique determines the overall 
within-individual relationship among paired measures 
assessed on two or more occasions.32
For paired t-tests and linear mixed models, ES were cal-
culated as Cohen’s d where ⩽ 0.2 was defined as trivial, 
0.2–0.3 as small, 0.4–0.8 as moderate, and ⩾ 0.8 as large. 
For the mixed models, Cohen’s d was calculated as the 
effect of condition (β) from linear mixed models divided 
by the baseline SD. For rmcorr, r value estimates of 0.1, 
0.3, and 0.5 were defined as small, medium, and large, 
respectively.33
Results
Participants
Complete data were collected on 22 of the 23 participants 
(23.8 years [SD 4.1], 73% F, 22.8 kg/m2 [SD 2.8]). One 
participant (20 years, F, 20.8 kg/m2) was excluded from 
data analysis due to inadequate image quality (i.e. the ultra-
sound image analysis software inadequately traced the ves-
sel walls). The PWV data for this participant were similar 
to the group mean (PWV 8.6 vs 8.5 m/s and PWVmin 7.1 vs 
6.9 m/s, respectively).
Hemodynamic data
Hemodynamic/control data are presented in Table 1. Across 
conditions (baseline, during cuff inflation, post-cuff infla-
tion), the brachial diameter did not significantly change (p 
= 0.720). There was a significant change in the shear rate 
parameters, including antegrade shear rate (p < 0.001), ret-
rograde shear rate (p < 0.001), and oscillatory index (p < 
0.001). Compared to baseline, each of the shear rate param-
eters significantly increased during partial occlusion (p < 
0.001 for all measures) but were not different to baseline 
post-occlusion (p = 1.000 for all measures).
There was a significant change in MAP (p < 0.001), 
DBP (p < 0.001), and SBP (p < 0.001). However, there 
was a non-significant change in central hemodynamic 
parameters, including cSBP (p = 0.142), Pb (p = 0.401), 
and Pf (p = 0.736).
Flow-Mediated Dilation (FMD)
Example data from one subject are shown in Figure 2, and 
the primary study outcomes are reported in Table 2. 
Following the 30-min endothelial dysfunction protocol, 
there was a large significant decrease (∆ = −3.10; 95% CI: 
–4.15, –2.05; ES = −1.3) in FMD. There was a moderate 
decrease in shear AUC (∆ = −4124; 95% CI: –6923, 
–1326; ES = −0.7). After adjusting FMD for the shear 
AUC stimulus, the decrease in FMD remained large (ES = 
−2.4, p < 0.001).
Pulse Wave Velocity (PWV)
Following the 30-min endothelial dysfunction protocol, 
there was a moderate significant increase (∆ = 0.38; 95% 
Figure 2. Example traces of FMD (A) and FMS (B) data 
recorded before and after the ED protocol.
(A) Diameters were recorded at 30 Hz for 2 min at baseline, during 
the 5 min of occlusion, and for 3 min following occlusion release. The 
diameters were analyzed offline using specialized image analysis soft-
ware. FMD was calculated as (Dmax – Dbase)/Dbase * 100. (B) PWV was 
automatically recorded every 3.5 s by the Vicorder device. For PWVbase, 
PWV was recorded continuously for 2 min and then averaged. For 
PWVmin, the minimum PWV following occlusion release was automati-
cally detected and then manually confirmed.
Dbase, baseline brachial diameter; Dmax, maximum brachial diameter during 
reactive hyperemia r; ED, endothelial dysfunction; FMD, flow-mediated 
dilation; FMS, flow-mediated slowing; PWV, pulse wave velocity; PWVbase, 
PWV at baseline; PWVmin, minimum PWV during reactive hyperemia.
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CI: 0.07, 0.69; ES = 0.5) in PWV. After adjusting for MAP, 
the effect remained moderate (ES = 0.5, p < 0.022). As 
reported in Figure 3A, there was a moderate but inconclu-
sive intra-individual association between FMD and PWV (r 
= −0.3; 95% CI: –0.67, 0.12; p = 0.121).
Flow-Mediated Slowing (FMS)
Following the 30-min endothelial dysfunction protocol, 
there was a moderate significant increase (∆ = 0.16; 95% 
CI: 0.05, 0.28; ES = 0.6) in PWVmin. After adjusting for 
MAP, the effect remained moderate (ES = 0.6, p < 0.009). 
There was a large intra-individual association between 
FMD and PWVmin (r = −0.61; 95% CI: –0.82, –0.24; p = 
0.002) (Figure 3B). The endothelial dysfunction protocol 
had an inconclusive effect on the remainder of the FMS 
parameters (Table 2), with non-significant intra-individual 
associations with FMD (p = 0.295–0.991).
Discussion
The objective of the current study was to determine the 
effects of acute endothelial dysfunction on PWV and 
PWVmin. Acute endothelial dysfunction, localized to the 
arm, resulted in a moderate and significant increase in arm 
PWV (∆ = 0.38 m/s) and PWVmin (∆ = 0.16 m/s). These 
Table 1. Hemodynamic measures (n = 22).
Baseline Cuff Post POverall PCuff PPost
 Mean (SD) Mean (SD) Mean (SD)  
Diameter (mm) 3.01 (0.41) 3.03 (0.45) 3.01 (0.44) 0.720  
Ante shear 186.3 (54.6) 305 (81.1) 175 (51.0) < 0.001 < 0.001 0.508
Retro shear –37.4 (27.4) –201 (90.3) –38.3 (30.3) < 0.001 < 0.001 0.952
Osc index 17.6 (13.4) 38.4 (10.4) 18.7 (13.3) < 0.001 < 0.001 0.749
MAP (mmHg) 78.3 (8.90) 79.5 (7.68) 82.3 (9.16) < 0.001 0.226 < 0.001
DBP (mmHg) 66.1 (7.02) 68.0 (7.47) 70.1 (7.48) < 0.001 0.022 < 0.001
SBP (mmHg) 112.3 (10.4) 112.9 (9.8) 115.7 (9.4) 0.008 0.602 0.004
cSBP (mmHg) 98.7 (9.4) 97.9 (8.6) 100.3 (9.4) 0.142  
Pb (mmHg) 11.8 (2.38) 11.3 (2.07) 11.5 (1.87) 0.401  
Pf (mmHg) 25.3 (4.16) 24.9 (3.98) 25.4 (4.41) 0.736  
Ante, antegrade; cSBP, central systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; Osc, oscillatory; Pb, aortic back-
ward pressure; Pf, aortic forward pressure; Retro, retrograde; SBP, systolic blood pressure.
Table 2. Primary outcomes pre- and post-acute endothelial 
dysfunction (n = 22).
Baseline Post p ES
 Mean (SD) Mean (SD)  
Shear AUC 30,426 (9080) 26,302 (7647) 0.006 –0.7
FMD (%) 6.17 (2.00) 3.07 (2.40) < 0.001 –1.3
PWV (m/s) 8.47 (1.17) 8.85 (1.17) 0.020 0.5
PWVmin (m/s) 6.87 (0.67) 7.04 (0.63) 0.009 0.6
PWVmin (%) 18.3 (6.51) 19.6 (5.62) 0.396 0.2
PWV30 (%) 15.9 (6.42) 15.9 (6.05) 0.995 0.0
PWV60 (%) 13.9 (6.39) 13.1 (6.01) 0.590 –0.2
PWV90 (%) 12.3 (6.42) 11.2 (5.87) 0.474 –0.2
PWV120 (%) 11.2 (6.47) 9.89 (5.74) 0.388 –0.2
AUC, area-under-the-curve; ES, effect size (Cohen’s d); FMD, flow-
mediated dilation; PWV, pulse wave velocity; PWVmin, minimum pulse 
wave velocity; PWV30–120, PWV integrated to 30–120 s during reactive 
hyperemia relative to baseline.
Figure 3. Intra-individual (pre- vs post-endothelial dysfunction) 
associations between FMD with PWV (A) and PWVmin (B) (n = 
22 repeated measures).
FMD, flow-mediated dilation; PWV, pulse wave velocity; PWVmin, mini-
mum pulse wave velocity.
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findings suggest that acute changes in PWV and PWVmin 
are at least partly driven by endothelial function.
Comparison to literature: PWV
In support of our hypothesis, the endothelial dysfunction 
protocol increased PWV by 0.38 m/s. We did not measure 
molecules associated with endothelial function in this study 
and can only speculate with respect to mechanisms. That 
being said, the increase in PWV following a known 
endothelial dysfunction protocol is in line with a number of 
studies reporting that infusion of a nitric oxide (NO) syn-
thesis inhibitor, NG-monomethyl-l-arginine (l-NMMA) or 
NG-nitro-l-arginine methyl ester (l-NAME), decreases 
compliance and increases PWV.12–15 Conversely, infusion 
of glyceryl trinitrate (nitroglycerin), which is metabolized 
to NO within the vascular wall, increases arterial compli-
ance and decreases PWV.12–14,16 While NO is not the only 
molecule regulating endothelial function,18 these previous 
findings do support a direct association between endothe-
lial function and arterial mechanical function. The current 
study extends these previous findings by demonstrating 
that non-specific local endothelial dysfunction increases 
arterial stiffness.
In the current study, we did see a 5.0 mmHg increase in 
MAP. MAP is a known determinant of PWV11 and could 
have driven the PWV response. Stewart et al.16 infused 
l-NMMA into a small (n = 8) sample of men and found that 
carotid–femoral PWV increased by 0.7 m/s. The authors 
argued that this response may have been driven by the 7.8 
mmHg increase in MAP. In support, infusion of norepineph-
rine and dobutamine resulted in similar increases in PWV 
and MAP to that observed with l-NMMA infusion. However, 
association is not causation and the authors did not manipu-
late NO while controlling for MAP, nor did they statistically 
control for changes in MAP. The authors did test the associa-
tion between MAP and PWV using ordinary least squares 
regression, but they used aggregate data and included the 
four conditions in the same model. This would have violated 
the assumption of statistical independence of errors, and 
could have resulted in an erroneous conclusion.32 The find-
ings of Stewart et al.16 are contrary to Wilkinson et al.,13 who 
used an ovine hind-limb model and reported that glyceryl 
trinitrate decreased PWV while l-NMMA increased PWV, 
and that these changes occurred independent of MAP. In the 
current study, we did statistically adjust for within-subject 
changes in MAP, and there remained a moderate ES increase 
in PWV. The intra-individual association between FMD and 
PWV was inconclusive, but we were not statistically pow-
ered to assess this association and the lack of association may 
have been driven by the restricted range of change values.34
Comparison to literature: FMS
We found that the endothelial dysfunction protocol had an 
inconclusive effect on each of the PWVmin% calculations 
(response relative to baseline). However, there was a mod-
erate significant increase (∆ = 0.16 m/s) in the raw FMS 
signal (i.e. PWVmin). As such, while a limited number of 
studies have reported that PWVmin% is reduced in those 
with cardiovascular complications,5–7 and that PWVmin% is 
associated with cardiovascular risk factors,9 these findings 
may not be attributable to endothelial function. Alternatively, 
the lack of effect of endothelial dysfunction on PWVmin% 
in the current study may be attributable to a shifting numer-
ator. Baseline PWV did increase by 0.38 m/s, which may 
have masked any change in the denominator, PWVmin. The 
PWVmin did increase during reactive hyperemia following 
endothelial dysfunction, which is consistent with the 
reduced peak arterial diameter and the assumption made by 
the Moens–Korteweg equation.17 As such, at least for stud-
ies investigating acute change in endothelial function, the 
raw PWVmin signal may be superior to PWVmin%. The use 
of PWVmin is supported by the large intra-individual asso-
ciation between FMD and PWV (r = −0.61).
Limitations and strengths
This study had several considerations, which were consid-
ered when designing the study. First, a healthy population 
sample was recruited to mitigate the risk of age or disease-
related influences on the primary outcomes. While our 
sample population did permit optimal signal-to-noise-ratio, 
future studies with older and clinical populations are now 
required to better generalize the findings. Second, we were 
not sufficiently powered to stratify our sample by sex. 
Further investigation is required to ascertain whether 
endothelial dysfunction similarly affects PWV and PWVmin 
in men and women. Third, the study was powered to esti-
mate the effect of the endothelial dysfunction protocol on 
PWVmin, not to determine associations between PWV and 
PWVmin with FMD. As such, the association data should 
not be directly used to adjudicate the hypothesis. Lastly, 
FMD was assessed simultaneously to PWVmin, meaning the 
upper arm and wrist cuffs were inflated to 50 mmHg 
throughout the FMD test. Pilot testing indicated that 50 
mmHg was the minimum inflation pressure for permitting 
quality pressure waveforms. We did consider conducting 
FMD and FMS measurements on separate arms, or on sepa-
rate days, but both alternative approaches would have 
introduced error variance. Rather, we completed both tests 
simultaneously, under the assumption that partial occlusion 
would have similarly affected both tests. Nonetheless, we 
cannot discount that partial occlusion did introduce some 
noise, particularly to the FMD data.
There were several strengths of the current study. First, 
we used the standard FMD test to confirm endothelial dys-
function. Second, we non-specifically induced local 
endothelial dysfunction. While previous studies have dem-
onstrated an association between PWV and endothelial 
function by targeting NO bioavailability,12–16 it should be 
acknowledged that NO is not the only molecule regulating 
endothelial function.18
Implications
Findings from this study indicate that PWVmin and PWV are 
viable options for measuring acute changes in endothelial 
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function. These options are attractive alternatives to existing 
methods, including FMD, because they are user-objective, 
automated, and likely more precise (reliable) than FMD. For 
example, one study compared the reliability of brachial FMD 
to brachial–radial PWVmin% in a group of 22 healthy partici-
pants (28–65 years old), reporting a coefficient of variation 
(CV) of 7.3% for PWVmin% and 26.6% for FMD.
7 The same 
study reported a CV of 3.3% for PWV, and, while PWVmin 
was not reported, the CV for the absolute change in PWV 
(PWVmin – baseline PWV) was 8.2%. The reported reliabil-
ity of FMD and PWV are in accordance with the available 
literature.35–37 To confirm viability, additional investigation 
is warranted to: (i) estimate the precision of PWVmin; (ii) 
confirm whether PWV and PWVmin decrease to a greater 
extent following a perturbation known to improve endothe-
lial function; (iii) confirm whether an increase or decrease in 
PWV and PWVmin corresponds with changes in the balance 
agonist and antagonistic molecules known to regulate 
endothelial function (e.g. NO and endothelin-1); (iv) use a 
technique which does not require partial occlusion to meas-
ure PWV (e.g. tonometry of photoplethysmography) to 
determine whether partial occlusion during reactive hypere-
mia modifies the PWVmin response; and (v) compare PWVmin 
and FMD in terms of the ability to discriminate between 
those with and without known cardiovascular disease.
Conclusions
The objective of the current study was to determine the 
effects of acute local endothelial dysfunction, induced by 
increasing retrograde shear stress in the arm for 30 min, on 
arm PWV and PWVmin. Endothelial dysfunction resulted in 
a moderate significant increase in PWV and PWVmin. These 
findings indicate that PWV and PWVmin are viable, user-
objective, and automated tools for monitoring acute 
changes in endothelial function.
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